Trial Profile
AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, CLINICAL PHASE 1 STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF VARICELLA VACCINE (LIVE ATTENUATED, FREEZE DRIED IP) OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 16 Jan 2018 New trial record